EP2882441
MEÐFERÐ IMMUNE-RELATED OG BÓLGUSJÚKDÓMUM
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
8.8.2013EP published:
29.4.2020EP application number:
13752753.7
EP translation filed:
18.6.2020Grant published:
15.7.2020EPO information:
European Patent Register
Max expiry date:
7.8.2033Expiry date:
7.8.2026Next due date:
31.8.2026
Title:
TREATMENT OF IMMUNE-RELATED AND INFLAMMATORY DISEASES
Timeline
Today
8.8.2013EP application
29.4.2020EP Publication
18.6.2020Translation submitted
15.7.2020Registration published
7.8.2026Expires
Owner
Name:
Celgene CorporationAddress:
86 Morris Avenue, Summit, NJ 07901, US
Inventor
Name:
SCHAFER, Peter, H.Address:
Somerset, NJ 08873, US
Name:
CHOPRA, RajeshAddress:
London SW15 1LE, GB
Name:
GANDHI, AnitaAddress:
Bernardsville, NJ 07924, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201261681491 PDate:
9.8.2012Country:
US
Number:
201261722718 PDate:
5.11.2012Country:
US
Classification
Categories:
A61K 31/5355, A61P 37/00, A61P 37/06, A61K 31/5377
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 8.7.2020
Expires: 7.8.2021
Payer: Árnason Faktor ehf.
Number: 9
Paid: 12.7.2021
Expires: 7.8.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 5.7.2022
Expires: 7.8.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 11.7.2023
Expires: 7.8.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 9.7.2024
Expires: 7.8.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 5.8.2025
Expires: 7.8.2026
Payer: Árnason Faktor ehf.